SWP
BIVV

Stratos Wealth Partners’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Stratos Wealth Partners’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,093
Closed -$59K – 3323
2017
Q4 		$59K Buy
+1,093
New +$59.8K ﹤0.01% 1440

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Stratos Wealth Partners's BIVV Position: Q1 2018 in Review

Stratos Wealth Partners sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,093 shares — an estimated $59K sold.

Stratos Wealth Partners first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $59K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Stratos Wealth Partners reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 1,093 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $59K.
  • Stratos Wealth Partners first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Stratos Wealth Partners's Bioverativ Inc. Common Stock position peaked at $59K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Stratos Wealth Partners's 13F filing for Q1 2018, filed 10 May 2018.